All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| STSA / Satsuma Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| TSVT / 2seventy bio, Inc.
|
|
|
|
|
|
|
|
| ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AVTE / Aerovate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
| MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
| EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
| SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SGEN / Seagen Inc
|
|
|
|
|
|
|
|
| CERS / Cerus Corporation
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
| RLMD / Relmada Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GTLB / GitLab Inc.
|
|
|
|
|
|
|
|
| EAR / Eargo, Inc.
|
|
|
|
|
|
|
|
| KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NRIX / Nurix Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
| OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
| RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SLGC / Standard BioTools Inc.
|
|
|
|
|
|
|
|
| BMEA / Biomea Fusion, Inc.
|
|
|
|
|
|
|
|
| PACB / Pacific Biosciences of California, Inc.
|
|
|
|
|
|
|
|
| RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| RANI / Rani Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| GRTX / Galera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| HRMY / Harmony Biosciences Holdings, Inc.
|
|
|
|
|
|
|
|
| TRDA / Entrada Therapeutics, Inc.
|
|
|
|
|
|
|
|
| EXAI / Exscientia plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ABCL / AbCellera Biologics Inc.
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| KOD / Kodiak Sciences Inc.
|
|
|
|
|
|
|
|
